Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 5,463 | 5,511 | 5,483 | 5,360 | 5,434 |
| Income taxes - deferred | -760 | -62 | -189 | -289 | 59 |
| Accounts receivable | 452 | 706 | -914 | -243 | 2,428 |
| Accounts payable and accrued liabilities | -299 | 2,486 | -1,174 | -170 | -3,661 |
| Other Working Capital | 2,240 | -739 | 1,284 | 1,949 | -5 |
| Other Operating Activity | -589 | -5,426 | 114 | -3,064 | -1,050 |
| Operating Cash Flow | $6,507 | $2,476 | $4,604 | $3,543 | $3,205 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -64 | -87 | -21 | -13 |
| Purchase Sale Intangibles | -283 | -215 | N/A | N/A | 0 |
| Other Investing Activity | 0 | 0 | -1,000 | 0 | 0 |
| Investing Cash Flow | $-316 | $-279 | $-1,087 | $-21 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,193 | -58,677 | -8,632 | -3,103 | -2,654 |
| Common Stock Repurchased | -7 | -783 | -833 | -176 | 0 |
| Other Financing Activity | -168 | 56,016 | 0 | 0 | 0 |
| Financing Cash Flow | $-5,368 | $-3,444 | $-9,465 | $-3,279 | $-2,654 |
| Exchange Rate Effect | 122 | -128 | 367 | 35 | -622 |
| Beginning Cash Position | 10,778 | 12,153 | 17,734 | 17,456 | 17,540 |
| End Cash Position | 11,723 | 10,778 | 12,153 | 17,734 | 17,456 |
| Net Cash Flow | $823 | $-1,247 | $-5,948 | $243 | $538 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,507 | 2,476 | 4,604 | 3,543 | 3,205 |
| Capital Expenditure | -316 | -279 | -1,087 | -21 | -13 |
| Free Cash Flow | 6,191 | 2,197 | 3,517 | 3,522 | 3,192 |